| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.029 |
0.9 |
| mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |